P

Inventor

COMMONS THOMAS JOSEPH

US13 patents
⚠️ This page may combine multiple inventors who share the name “COMMONS THOMAS JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WYETH CORP

5 patents
US6589970B2Jul 8, 2003

6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

WYETH CORP20 citations89
US7618990B2Nov 17, 2009

Oxazolidone derivatives as PR modulators

WYETH CORP9 citations82
US7534894B2May 19, 2009

Biphenyloxy-acids

WYETH CORP6 citations60
US7618989B2Nov 17, 2009

Tricyclic oxazolidone derivatives useful as PR modulators

WYETH CORP0 citations40
US7538107B2May 26, 2009

Oxazinan-2-one derivatives useful as PR modulators

WYETH CORP0 citations40

AMERICAN HOME PROD

5 patents
US5977170ANov 2, 1999

Elevation of HDL cholesterol by 4-[(aminothioxomethyl)hydrazono]-4-arylbutyl carbamates

AMERICAN HOME PROD17 citations82
US6049006AApr 11, 2000

Elevation of HDL cholesterol by N-[2-[(aminothioxomethyl) hydrazono]-2-arylethyl]amides

AMERICAN HOME PROD9 citations72
US6034272AMar 7, 2000

Elevation of HDL cholesterol by N-[4-[(aminothioxomethyl) hydrazono]-4-arylbutyl]amides

AMERICAN HOME PROD8 citations72
US5968975AOct 19, 1999

Elevation of HDL cholesterol by 2-[(aminothioxomethyl)-hydrazono]-2-arylethyl carbamates

AMERICAN HOME PROD0 citations50
US5952354ASep 14, 1999

Tris carbamic acid esters: inhibitors of cholesterol absorption

AMERICAN HOME PROD1 citations43

WYETH LLC

2 patents
US7649007B2Jan 19, 2010

Oxazolidine derivatives as PR modulators

WYETH LLC0 citations40
US7652018B2Jan 26, 2010

Imidazolidin-2-one derivatives useful as PR modulators

WYETH LLC0 citations39

(unassigned)

1 patent
US6008362ADec 28, 1999

Elevation of HDL cholesterol by 2-(-4-chlorol-1-aryl-butylidene)-hydrazinecarbothioamides

19 citations85